Paid Social
Paid social for medical practices: Meta ads measured to the consult.
Facebook and Instagram put your practice in front of patients who were not searching for you yet. That still works, and for elective procedures it works well. What changed is the measurement: Meta now restricts what health-related advertisers can track, and most agencies either went quiet about it or engineered around it. We did neither. We rebuilt the program around the rules and kept the reporting honest.
Why paid social
Search captures demand. Social creates it.
A patient searching "hair transplant near me" already wants the procedure. Paid search competes for that patient, and so does every practice in your market, in an auction that gets more expensive every year. Paid social works one step earlier: it reaches the person who has thought about the procedure for two years but never typed the query, the one researching quietly, the one who did not know a practice like yours was twenty minutes away.
For elective, visual, life-improving procedures, that earlier moment is where preference gets formed. The practice that introduced itself well before the search often wins the search, and frequently prevents it from happening at all, because the patient arrives already knowing who they want to see. That is why paid social runs alongside search in a healthy program rather than instead of it: one channel creates the demand the other one closes.
It is also, per impression, the least expensive way to stay present in your market between decisions. Elective patients deliberate for months. A practice that is visible for all of those months, usefully and tastefully, is running a different race than one that only appears at the final search.
The craft is different, though. Social advertising is interruption, so the creative has to earn attention honestly, and in healthcare it has to do that inside two rulebooks at once: the platform’s ad policies and the platform’s newer restrictions on health data itself. The second rulebook is the one nobody explains, so we will.
Frame one · Educate
Answer the question patients research quietly
Education-led hooks earn the stop honestly. No before/after bait, nothing that implies the viewer has a problem.
Frame two · Show the practice
The physician, the place, the tone
Real practice presence builds the familiarity data-based targeting can no longer buy.
Frame three · Invite
Make the consult the easy next step
The offer is the consultation, the honest next step, never pressure mechanics.
The creative sequence that does the work: educate, show the practice, invite the consult. As data-based targeting narrows, the creative is the targeting.
The part nobody explains
Meta’s health data restrictions, in plain language.
If your Facebook results "suddenly went dark" in the last couple of years, this is almost certainly why. It deserves a plain explanation, because you cannot evaluate any agency’s paid social pitch, including ours, without understanding it. Four facts cover the mechanism.
Meta classifies health advertisers
Meta identifies businesses whose data relates to health, medical practices included, and restricts what their tracking tools are allowed to send back to the platform. This is a data policy applied at the account and pixel level, not a judgment about your ads, your practice, or anything you did wrong.
Lower-funnel events get blocked
For restricted accounts, the events closest to a patient decision, form submissions on procedure pages, booking events, consult requests, are the ones Meta stops accepting. The pixel appears to work, campaigns keep spending, and the conversions your reports were built on quietly stop arriving. There is no red banner. The numbers just fade.
That is why the numbers went dark
A practice that saw steady reported conversions one quarter and near zero the next usually did not lose its results. It lost its measurement. The distinction matters enormously, because the two problems have completely different fixes, and an agency that cannot tell you which one you have is guessing with your budget.
Retargeting narrows with it
Audiences built from health-intent behavior, people who visited your procedure pages, people who started a consult form, are exactly what the restrictions exist to prevent. Retargeting does not disappear entirely, but it narrows to what the rules allow, and the audiences an agency promised you in 2021 are not the audiences anyone can compliantly build today.
The workaround trap
If a fix involves renaming events, walk away.
There is a popular species of advice for restricted accounts: rename your conversion events to something neutral so the classifier stops recognizing them, or move tracking server-side so the data travels by a pipe Meta scrutinizes less. Both are presented as technical fixes. Neither is one.
The restriction follows the data, not the label on it and not the pipe it travels through. An event called "PurpleButterfly" that fires when someone requests a hair loss consultation is health data with a costume on, and sending it server-side changes the transport, not the substance. For a practice carrying HIPAA obligations, this is worse than useless: it converts a platform measurement restriction, an inconvenience, into potential legal exposure, a liability, and it does so quietly, in the tracking configuration, where nobody at the practice would ever see it.
We state this on a sales page because it is the single most important question to ask anyone pitching you paid social right now: how do you handle Meta’s health data restrictions? If the answer involves renaming, relabeling, or "a server-side workaround," the agency has misread the mechanism, and your practice, not the agency, would carry the risk. There is a legitimate version of every one of those tools, and the difference between using them and abusing them is whether the data being sent is data the platform allows a health advertiser to send. That is the test, and it is the one we apply before anything ships.
Straight answers
What we track and retarget. What we will not.
What we can do
- Measure top-of-funnel signal: reach, engaged visits to general pages, and upper-funnel events within the platform’s rules
- Capture every inquiry first-party at the form and phone, where measurement is complete and compliant
- Track leads through consult, show, and procedure in our own reporting, outside Meta entirely
- Report a compliant slice back to Meta so campaign optimization keeps learning from real outcomes
- Build audiences from non-health surfaces and broad creative engagement, within policy
What we will not do
- Place tracking pixels on procedure, consult, or form pages carrying health intent
- Retarget people based on health-intent browsing, whatever tooling makes it technically possible
- Rename or relabel restricted events to slip past classification
- Present server-side delivery as a way to send data the platform has restricted
- Build lookalike or custom audiences from patient lists
The honest version costs some platform-side reporting convenience, and we will not pretend otherwise. What it buys is worth more: your practice’s measurement rests on first-party ground no policy change can pull away, your ads keep running while accounts built on workarounds get restricted, and every number in your report is one you could explain to a compliance officer without flinching.
Platform mix
Meta first. The others when they earn it.
Facebook and Instagram remain the core of paid social for elective practices: the audience is broad enough to matter in every local market, the targeting that remains is workable, and the creative formats fit how patients actually research providers. That is where the program starts and where most of the budget lives.
Other platforms enter on evidence, not fashion. Short-form video channels can work for practices with the creative appetite to feed them, and professional networks occasionally earn a slot for specific verticals and offers. Each expansion is a deliberate test with a named expected effect and a budget cap, run after Meta is performing, never a default line item. Spreading a practice’s budget across four platforms to make a slide look thorough is how none of them get enough data to work.
The health data restrictions described above apply in spirit everywhere: every major platform is tightening what health advertisers can send, at different speeds. The first-party measurement architecture we build is platform-agnostic on purpose, so when the next platform tightens, your reporting does not go dark a second time.
Campaign architecture
Built consult-first, vertical by vertical.
Creative that earns the stop
Real practice imagery, real physician presence, and education-led hooks that respect how personal these decisions are. In elective healthcare the creative is the targeting: what a piece of content says determines who stops for it, and as data-based targeting narrows under the restrictions, that principle has quietly become the whole game. The practices winning on social right now are winning on creative, not on audience tricks.
Offers a careful patient will take
The campaign sells the consultation, the honest next step, not the surgery. Offer structure varies by vertical: a candidacy consult reads differently for hair restoration than for dental implants or LASIK, and the language, imagery, and proof points shift with it. What never changes is the respect for the reader: no pressure mechanics, no manufactured urgency, nothing that would embarrass the physician whose name is on the door.
Audiences within the rules
Geography, demographics, broad interest signal, and creative-engagement audiences, tuned by what the platform still does genuinely well: finding more of the people who respond to what you show them. No health-behavior segments, no patient-list lookalikes, no reconstructions of either by clever proxy. The targeting is compliant by construction, which means it will still be running next year.
Full-funnel structure
Awareness creative introduces the practice, consideration creative answers the questions patients actually have, and conversion creative makes the consult easy to request. Each stage is judged on its own job, not on a single blended metric that hides where the funnel actually leaks. Budgets shift between stages based on what the first-party data says, not on platform defaults.
Shaped per vertical forhair restorationaesthetic medicinedentalvision
From lead to revenue
The measurement lives with us, not with the pixel.
Because platform-side tracking is restricted, the honest place to measure paid social is after the click, in systems the practice controls. Every inquiry from social is captured first-party with its source preserved, then followed through the stages that matter: contacted, consultation booked, showed, procedure. That reporting runs on RootLogic, our offline conversion tracking, and it is how a channel Meta cannot fully measure still gets judged on consults and revenue rather than on reach.
A compliant, de-identified slice of that outcome signal is returned to the platform where the rules allow, so campaign delivery keeps optimizing toward people who become patients rather than people who click. The practice sees the full honest ladder either way, and nothing in that slice would identify a patient or a health condition to anyone.
This is the same closed loop that runs under every channel we manage, which has a useful side effect: social, search, and organic are all judged by the same definitions, on the same report, so budget can move between them on evidence instead of on whichever channel manager argued loudest.
What you own
The ad account, the page, the pixel, the audiences. Yours.
Everything the program builds lives in assets your practice controls: the Meta Business Manager and ad account, the Facebook and Instagram pages, the pixel and its history, every audience, every creative asset, every report. In writing, from day one. If we part ways, the machine keeps running and whoever you hire next inherits it whole, along with documentation of how it was built and why. The relationship should be held together by results, not by custody, and an agency confident in its results has no reason to hold anything else. Ask for the same commitment in writing from anyone else you are considering.
Creative and compliance review
Every ad clears two bars before it spends a dollar.
Meta’s written ad policies for health and appearance are strict and unevenly enforced, which tempts advertisers to test the line. We do not, because the account-level cost of accumulated violations lands on the practice, not the agency. Before-and-after imagery is used only where platform rules and good taste allow, copy describes the service rather than the reader’s body or condition, and claims stay inside what the practice can substantiate. Nothing implies the viewer has a problem. Nothing promises an outcome no physician would promise.
This review discipline is why compliant accounts age well: ad delivery stabilizes, costs stop spiking around policy flags, and the practice’s account quality becomes an asset instead of a running risk. The same standards protect you on the medical advertising side, where a careless claim can create problems well beyond a disapproved ad, and they are the same standards our medical content passes everywhere else, so your brand sounds like one practice across every surface.

Wondering what your current ads would flag? Check them.
Run the free Compliance AuditThe first 90 days
What the start of the program actually looks like.
Weeks 1 to 2
Account and asset audit, ownership put in the practice’s name where it is not already, measurement architecture wired first-party, and a compliance review of any existing tracking, creative, and audiences. Anything that violates the data rules is removed before we scale what remains, because scaling on top of a violation just makes it a bigger one.
Weeks 3 to 6
First campaigns live: consult-first offers, three to five creative concepts per vertical priority, audiences built within the rules, and conservative budgets while the first-party measurement accumulates real outcomes to judge by. Weekly creative reads begin, looking at what earns attention and what earns inquiries, which are not always the same thing.
Weeks 7 to 12
Creative iteration on what the data supports, budget shifting toward the concepts producing consults rather than clicks, retargeting live within the compliant carve-out, and the first honest read of cost per booked consultation from social, stated with its confidence level rather than dressed up as certainty.
By day ninety you should know what a social-sourced consultation costs in your market, measured first-party. That number, not reach, not engagement, not "brand lift," is what the program gets judged on.
Results framing
Judge social on consults produced, on a slower clock than search.
Paid social builds preference before it books consults, so the honest evaluation window is longer than search: expect the first meaningful read on cost per consult around month three, improving as creative learning and outcome data accumulate. Judging the channel on week-two form counts is how good programs get cancelled and bad ones get renewed. Some of what social produces will also surface elsewhere, as branded searches and direct bookings from people the ads reached weeks earlier, and we would rather tell you that plainly than claim it all with attribution arithmetic.
We publish the definitions behind every number before launch, report the full lead-to-procedure ladder monthly, and label estimates as estimates. No invented benchmarks, no borrowed case-study math, no screenshots of platform dashboards we just told you not to trust. The methodology page shows exactly how the loop closes.
Questions
Paid social, asked straight
Why did our Facebook results suddenly stop reporting conversions?
Almost certainly Meta’s health data restrictions. Meta classifies medical practices as health advertisers and blocks the lower-funnel tracking events, form submissions, booking events, that reports were built on. The ads usually kept working; the measurement went dark. The fix is first-party measurement after the click, not pixel repairs, and any agency proposing to rename events to restore the numbers is proposing evasion.
Can a medical practice legally run Facebook and Instagram ads?
Yes. The restrictions are about data, not about advertising. A practice can absolutely run compliant Meta campaigns: the ads themselves must follow health and appearance policies, and the tracking must not send health-related behavior to the platform. What changed is how results get measured, which now has to happen first-party, and which agencies handle well or badly. Running ads was never the problem.
Can we retarget our website visitors?
Partially. Audiences built from health-intent behavior, visits to procedure pages, started consult forms, are what the restrictions exist to prevent, and we will not build them by any route. Retargeting from non-health surfaces and from creative engagement inside the platform remains available within policy. The carve-out is narrower than agencies used to enjoy, and strong creative-led targeting has replaced most of what it did.
How do we know Facebook ads produce patients and not just form fills?
Because the measurement follows every social inquiry past the form: contacted, consultation booked, showed, procedure completed, all captured first-party in systems the practice owns. The monthly report shows that full ladder, so a campaign producing cheap forms that never become consults gets caught and cut, and one producing fewer but better inquiries gets the budget it earned.
Who owns the ad account, page, and pixel if we leave?
Your practice does, in writing, from the first day. The Meta Business Manager, ad account, Facebook and Instagram pages, pixel history, audiences, and creative all live in assets you control. If the engagement ends, nothing is surrendered or rebuilt: the account keeps its learning history and your next team inherits a working system rather than a cold start.
Find out what paid social can honestly do for your practice.
The free Practice Growth Audit includes a read of your current social presence, your compliance exposure, and whether your measurement would survive the restrictions that caught everyone else. Built by hand, delivered in days, yours to keep either way.